Advertisement
No access
Special Viewpoints

Selection Forces and Constraints on Retroviral Sequence Variation

Science
11 May 2001
Vol 292, Issue 5519
pp. 1106-1109

Abstract

All retroviruses possess a highly error-prone reverse transcriptase, but the extent of the consequent sequence diversity and the rate of evolution differ greatly among retroviruses. Because of the high mutability of retroviruses, it is not the generation of new viral variants that limits the extent of diversity and the rate of evolution of retroviruses, but rather the selection forces that act on these variants. Here, we suggest that two selection forces—the immune response and the limited availability of appropriate target cells during transmission and persistence—are chiefly responsible for the observed sequence diversity in untreated retroviral infections. We illustrate these aspects of positive selection by reference to specific lentiviruses [human and simian immunodeficiency viruses (HIV and SIV)] and oncoviruses [feline leukemia virus (FeLV) and human T cell leukemia virus (HTLV)] that differ in their extent of variation and in disease outcomes.

Get full access to this article

View all available purchase options and get full access to this article.

REFERENCES AND NOTES

1
Wei X., et al., Nature 373, 117 (1995).
2
Ho D. D., et al., Nature 373, 123 (1995).
3
Nei M., Gojobori T., Mol. Biol. Evol. 3, 418 (1986).
4
Mansky L. M., J. Virol. 74, 9525 (2000).
5
J. L. Rohn, J. Overbaugh, in Persistent Viral Infections, I. S. Y. Chen, R. Ahmed, Eds. (Wiley, Chichester, UK, 1999), pp. 379–408.
6
Anderson M. M., et al., Science 287, 1828 (2000).
7
Jarrett O., Russell P. H., Int. J. Cancer 21, 466 (1978).
8
Donahue P. R., et al., J. Virol. 62, 722 (1988).
9
Overbaugh J., et al., Science 239, 906 (1988).
10
Temin H. M., Trends Genet. 7, 71 (1991).
11
Overbaugh J., et al., Nature 332, 731 (1988).
12
Takeuchi Y., et al., J. Virol. 66, 1219 (1992).
13
van Zeijl M., et al., Proc. Natl. Acad. Sci. U.S.A. 91, 1168 (1994).
14
Miller D. G., et al., Proc. Natl. Acad. Sci. U.S.A. 91, 78 (1994).
15
Kavanaugh M. P., et al., Proc. Natl. Acad. Sci. U.S.A. 91, 7071 (1994).
16
Cosset F. L., et al., J. Virol. 69, 6314 (1995).
17
Ina Y., Gojobori T., J. Mol. Evol. 31, 493 (1990).
18
Niewiesk S., et al., J. Virol. 68, 6778 (1994).
19
Slattery J. P., et al., Genome Res. 9, 525 (1999).
20
Uchiyama T., Annu. Rev. Immunol. 15, 15 (1997).
21
Nagai M., et al., J. Neurovirol. 4, 586 (1998).
22
Cavrois M., et al., Oncogene 12, 2419 (1996).
23
Taylor G. P., et al., J. Virol. 73, 10289 (1999).
24
Hanon E., et al., Blood 95, 1386 (2000).
25
Bangham C. R. M., Curr. Opin. Immunol. 12, 397 (2000).
26
Kannagi M., et al., Int. Immunol. 3, 761 (1991).
27
Niewiesk S., et al., J. Virol. 69, 2649 (1995).
28
Zinkernagel R. M., Hengartner H., Immunol. Today 18, 258 (1997).
29
Bush R. M., et al., Science 286, 1921 (1999).
30
B. Korber et al., in The Changing Face of HIV and AIDS, R. Weiss et al., Eds. (Oxford Univ. Press, Oxford, in press).
31
Price D., et al., Proc. Natl. Acad. Sci. U.S.A. 94, 1890 (1997).
32
Borrow P., et al., Nature Med. 3, 205 (1997).
33
Kimata J. T., et al., Nature Med. 5, 535 (1999).
34
Delwart E. L., et al., J. Virol. 68, 6672 (1994).
35
Wolinsky S. M., et al., Science 272, 537 (1996).
36
Lukashov V., et al., J. Virol. 69, 6911 (1995).
37
Hoffman T. L., Doms R. W., AIDS 12, S17 (1998).
38
Liu R., et al., Cell 86, 367 (1996).
39
Samson M., et al., Nature 382, 722 (1996).
40
McKnight A., et al., J. Virol. 69, 3167 (1995).
41
Hoover E. A., et al., J. Am. Vet. Med. Assoc. 199, 1392 (1991).
42
M. A. Nowak, R. M. May, Virus Dynamics (Oxford Univ. Press, New York, 2000).
43
J.O. is an Elizabeth Glaser Scientist. We thank M. Emerman, Q. Sattentau, J. Weber, and M. McClure for comments on the manuscript.

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 292 | Issue 5519
11 May 2001

Submission history

Published in print: 11 May 2001

Permissions

Request permissions for this article.

Authors

Affiliations

Julie Overbaugh [email protected]
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. E-mail: [email protected]
Charles R. M. Bangham [email protected]
Imperial College School of Medicine, London W2 1PG, UK. E-mail: [email protected]

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Full Text

FULL TEXT

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media